DrugPatentWatch Database Preview
Drugs in Development Information for Betadex
What is the development status for investigational drug Betadex?
Betadex is an investigational drug.
There have been 8 clinical trials for Betadex.
The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2016.
The most common disease conditions in clinical trials are Schizophrenia, Psychomotor Agitation, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Bayer, Yang Fude, and Pfizer.
There are two US patents protecting this investigational drug and twenty-nine international patents.
Summary for Betadex
| US Patents | 2,381 |
| International Patents | 29,256 |
| US Patent Applications | 6,175 |
| WIPO Patent Applications | 784 |
| Japanese Patent Applications | 107 |
| Clinical Trial Progress | Phase 3 (2016-10-01) |
| Vendors | 31 |
Recent Clinical Trials for Betadex
| Title | Sponsor | Phase |
|---|---|---|
| Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440 | Janssen Research & Development, LLC | Phase 1 |
| A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe | Janssen Sciences Ireland UC | Phase 1 |
| The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation | Pfizer | Phase 4 |
Clinical Trial Summary for Betadex
Top disease conditions for Betadex
Top clinical trial sponsors for Betadex
US Patents for Betadex
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Betadex | Start Trial | Therapeutic and imaging compositions and uses thereof | Purdue Research Foundation (West Lafayette, IN) | Start Trial |
| Betadex | Start Trial | Hard coating composition | LG CHEM, LTD. (Seoul, KR) | Start Trial |
| Betadex | Start Trial | Therapeutic nuclease compositions and methods | University of Washington (Seattle, WA) | Start Trial |
| Betadex | Start Trial | Pharmaceutical composition for preventing or treating skin cancer comprising Panax spp. plant extract and method of preventing or treating skin cancer in a subject using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (Seoul, KR) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Betadex
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Betadex | Canada | 2911906 | 2033-05-07 | Start Trial |
| Betadex | European Patent Office | 2994755 | 2033-05-07 | Start Trial |
| Betadex | World Intellectual Property Organization (WIPO) | 2014182804 | 2033-05-07 | Start Trial |
| Betadex | China | 104487494 | 2032-05-31 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
